CXCL1 and cancer: In addition, CXCL1/5 promotes neutrophil recruitment [69] and IL-17A produced by neutrophils stimulates EOC stromal cells to secrete CXCL1, thereby attracting more neutrophils to form an aberrant immune environment that promotes cancer progression and suppresses anti-tumor immune responses [19].